Risperidone‐induced tardive dyskinesia and parkinsonism
暂无分享,去创建一个
[1] D. Folks,et al. The Omnibus Budget Reconciliation Act: impact on psychotropic drug use in long-term care facilities. , 2009, Perspectives in psychiatric care.
[2] R. Bridgman,et al. Risperidone-induced extrapyramidal reactions , 1995, The Lancet.
[3] J. Addington,et al. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder. , 1995 .
[4] I. McKeith,et al. Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.
[5] J. Feighner,et al. Bupropion: a review of its mechanism of antidepressant activity. , 1995, The Journal of clinical psychiatry.
[6] G. Chouinard. Effects of Risperidone in Tardive Dyskinesia: An Analysis of the Canadian Multicenter Risperidone Study* , 1995, Journal of clinical psychopharmacology.
[7] Howland Rh. Biochemical and clinical effects of buspirone augmentation. , 1994 .
[8] D. Owens. The spectrum of depressive phenomena after spousal bereavement. , 1994 .
[9] Robert Miller,et al. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia , 1993, Biological Psychiatry.
[10] J. Jankovic,et al. Cocaine‐related movement disorders , 1993, Movement disorders : official journal of the Movement Disorder Society.
[11] A. Walters,et al. Persistent movement disorders induced by buspirone , 1993, Movement disorders : official journal of the Movement Disorder Society.
[12] C. Olanow,et al. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.
[13] A. Strauss. Oral dyskinesia associated with buspirone use in an elderly woman. , 1988, The Journal of clinical psychiatry.
[14] J. Nutt,et al. Buspirone in Parkinson's disease. , 1986, Clinical neuropharmacology.
[15] E. Friedman,et al. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia. , 1983, The Journal of pharmacology and experimental therapeutics.